Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics (Q31374188)

1 July 2017

1 reference

title

Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics (English)

1 reference

1 July 2017

1 reference

Hieble JP

1

1 reference

1 July 2017

publication date

1 March 2000

1 reference

Pharmaceutica acta Helvetiae

1 July 2017

published in

1 reference

1 July 2017

volume

74

1 reference

1 July 2017

issue

2-3

1 reference

1 July 2017

page(s)

163-171

1 reference

A study of the adrenotropic receptors

1 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Synthesis of a selective alpha-2A adrenoceptor antagonist, BRL 48962, and its characterization at cloned human alpha-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Heterogeneity of alpha-2 adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Mechanisms contributing to the arrhythmogenic influences of alpha 1-adrenergic stimulation in the ischemic heart

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

What do antagonists tell us about alpha-adrenoceptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Alpha1-adrenoceptor subtype activation increases proto-oncogene mRNA levels. Role of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Carvedilol (Kredex&reg;) Reduces Infarct Size in a Canine Model of Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

In vitro characterization of the alpha-adrenoceptors in human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Clonidine in child and adolescent psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Is there a third heart beta-adrenoceptor?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Modulation of human cardiac function through 4 beta-adrenoceptor populations

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

(-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Alpha1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Pharmacological options in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Differentiation of Receptor Systems activated by Sympathomimetic Amines

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Modulation of delayed afterdepolarisations by alpha 1 adrenergic receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Central hypotensive effects of the alpha2a-adrenergic receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Characterization of postjunctional alpha-adrenoceptors in the pithed mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Evaluating the effects of an alpha-2 adrenoceptor antagonist on erectile function in the human male. 2. The erectile response to erotic stimuli in men with erectile dysfunction, in relation to age and in comparison with normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Insights from in vivo modification of adrenergic receptor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Alpha-sympathomimetic inhibition of Neurogenic vasoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Role of alpha 1-adrenoceptor activity in progression of cardiac hypertrophy in guinea pig hearts with pressure overload

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

NS-49, an alpha 1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

A re-investigation of questionable subclassifications of presynaptic alpha2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Tamsulosin : A Review of its Pharmacological Properties and Therapeutic Potential in the Management of Symptomatic Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

The rat lipolytic β-adrenoceptor: Studies using novel β-adrenoceptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6865%2899%2900030-8

7 January 2021

10.1016/S0031-6865(99)00030-8

Identifiers

DOI

1 reference

1 July 2017

1 reference